Last updated 2026-07-20
Total raised
—
Last: Undisclosed Round 2024-09
Stage
Seed
Founded
2021
Headcount
10
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences
Website ↗Registrar ID: 516542305 (Coltac Therapeutics)
About
Coltac Therapeutics is a biotech startup advancing oncology and non-oncology programs through BOND+ – a proprietary, bacteria-based synthetic screening platform designed for the discovery of novel molecular glues for targeted protein degradation. The company utilizes a multimodal, iterative approach combining deep structural biology expertise and computational approaches to select specific E3-ligase libraries for expression in a proprietary high-throughput E. Coli-based positive selection screening system. Molecular Glue drug candidates are then discovered based on their ability to enhance binding of an E3 ligase to the target protein.
Headcount over time
10 employees (2026-09) · 1 point
Offices
Ra'anana, Israel · HQ / main office
Q&A
- What is Coltac Therapeutics' primary focus?
- Coltac Therapeutics is a preclinical pharmaceutical company developing a bacteria-based synthetic positive selection screening system for discovering molecular glues.
- When was Coltac Therapeutics founded?
- Coltac Therapeutics was founded in January 2022.
- How many employees does Coltac Therapeutics have?
- Coltac Therapeutics has 1-10 employees.
- What is the total amount of funding Coltac Therapeutics has raised to date?
- Coltac Therapeutics has raised a total of $5,000,000 USD.
- When was Coltac Therapeutics' most recent funding round and who were the lead investors?
- Coltac Therapeutics' most recent funding round was in September 2024, with aMoon Fund as a lead investor.
- What is Coltac Therapeutics' current funding stage?
- Coltac Therapeutics is currently in the Seed funding stage.
- In which sector does Coltac Therapeutics primarily operate?
- Coltac Therapeutics operates primarily in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Where is Coltac Therapeutics headquartered?
- Coltac Therapeutics is headquartered in Ra'anana, Israel.
Team · 12
Gali Prag
Founder · Co-founder & board member
Yaron Sfadyah
CEO
Liraz Harel
VP of R&D
Orli Even-Or
Director of R&D
Michael Mullokandov
Senior Scientist
Hana Boocholez-Vardi
Scientist
Valeria Arkadash
Senior scientist
Alexandra Brodezki
scientist
Daniel Feder
Computational Scientist, Structural Biologist
Yaron Daniely
Board member
Sarit Steinberg
Board member
Tali Aloya
Board member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcare
Business model
B2B
Tags
oncologybiopharmaceuticalbiotechnologydrug-discoveryproteins
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | coltactx.com |
|---|
Identifiers & details
| Founded | 2021 |
|---|---|
| Employees (exact) | 10 |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516542305 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-01-20 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 1 — charge (1) |
| Registered address | ירושלים 34 רעננה |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-31 | רישום שעבוד |